Diagnosis of disappearing lung syndrome as a complication of non-hospital pneumonia of viral etiology (COVID-19)

Abstract

BACKGROUND. Particularly dangerous coronavirus disease (COVID-19) continues to be one of the urgent problems of mankind. Researchers around the world have noted that in the third wave of the COVID-19 pandemic, the disease became more aggressive. Physicians more often began to pay attention to the occurrence of progressive lung degradation, in particular bullous-emphysematous changes in the lungs, and in those patients who did not have a history of chronic lung disease. Due to the fact that in the acute phase of coronavirus infectious computed tomography (CT) of the chest according to the national protocol is not required, the timing of this complication remains unknown.

OBJECTIVE. To study the timing of the onset of disappearing lung syndrome as one of the complications of communityacquired pneumonia of viral etiology (COVID-19) and to demonstrate on clinical observations according to CT.

MATERIALS AND METHODS. A group of patients referred for treatment to the SI “National institute of phthisiology and pulmonology named after F.G. Yanovsky of the NAMS of Ukraine”. Among the examined according to CT of the chest identified 21 patients (15 men and 6 women aged 24 to 67 years) with radiological signs of disappearing lung syndrome. Nine of them (7 men and 2 women aged 24 to 54 years) were treated at the institute during the acute period of the disease. Another 12 (8 men and 4 women aged 27 to 67 years) were referred to the institute from other medical institutions, where they were treated for community-acquired pneumonia of viral etiology (COVID-19) 3-4 months ago.

RESULTS AND DISCUSSION. CT analysis of the chest in 21 patients with disappearing lung syndrome showed that 9 (42,9 %) of them were diagnosed with bullous-emphysematous changes in the acute period of the disease – from 1 to 2 months, and in 12 (57,1 %) – in the postpartum period, in the period from 3 to 4 months. At the same time, patients had difficulty breathing, coughing, no significant improvement in general condition after previous inpatient treatment. Three of 12 patients noted deterioration of the general condition.

CONCLUSIONS. In severe patients with community-acquired pneumonia of viral etiology (COVID-19), a progressive pulmonary degradation syndrome with the formation of bullous-emphysematous changes can occur both in the acute period of the disease and develop or progress in the postpartum period (after 3-4 months after inpatient treatment). CT of the chest should be performed in all patients after inpatient treatment and elimination of acute respiratory distress syndrome, which will allow timely diagnosis of changes in lung architecture and complications of the disease.

Keywords: COVID-19, disappearing lung syndrome, diagnostics, community-acquired pneumonia, computed tomography.

References

Zaikov S.V. Terapiia patsiientiv iz COVID-19: klinichni doslidzhennia ta rekomendatsii v riznykh krainakh. Infusion & Chemotherapy. 2020; 4: 5-12. DOI: 10.32902/2663-0338-2020-4-5-12.

Raznatovskaya E.N., Mihaylova A.A., Steshina M.S. i dr. Sindrom ischezayuschego legkogo pri tuberkuleze. Novosti meditsinyi i farmatsii. Allergologiya i pulmonologiya. 2014; 520: 20-26.

Kosarev V.V., Babanov S.A. Spravochnik pulmonologa. Rostov-na-Donu: Feniks, 2011. 445 p.

Koval H.Yu. Promeneva diahnostyka. Kyiv: Medytsyna Ukrainy, 2009. Vol. 1. 832 p.

Zhyindirov B.K. Osobennosti kliniki, diagnostiki i metodov lecheniya bulleznoy bolezni legkih, oslozhnennoy spontannyim pnevmotoraksom: avtoref. dis… kand. med. nauk. Bishkek, 2012. 19 p.

Pahomov G.L., Islambekov E.S., Ismailov D.A. Taktika lecheniya nespetsificheskogo spontannogo pnevmotoraksa (metodicheskie rekomendatsii). Tashkent, 2010. 13 p.

Lynnyk M.I., Ignatieva V.I., Gumeniuk G.L., Svyatnenko V.A. ta in. Diahnostyka uskladnenoho perebihu nehospitalnoi pnevmonii virusnoi etiolohii (COVID-19) iz vykorystanniam kompiuternoi tomohrafii orhaniv hrudnoi klitky. Infusion & Chemotherapy. 2021; 2: 11-18. DOI: 10.32902/2663-0338-2021-2-11-18.

Lynnyk M.I., Ignatieva V.I., Gumeniuk G.L., Tarasenko O.R. ta in. Otsinka efektyvnosti likuvannia khvorykh na nehospitalnu pnevmoniiu virusnoi etiolohii (COVID-19) iz zastosuvanniam syndromno-patohenetychnoi maloobiemnoi infuziinoi terapii za danymy kompiuternoi tomohrafii. Infusion & Chemotherapy. 2021; 2: 31-38. DOI: 10.32902/2663-0338-2021-2-31-38.

Cecchini R., Cecchini F. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Medical Hypotheses. 2020; 143: 110102.

Komaroff A. The tragedy of the post-COVID “long haulers”. Available at: https://www.health.harvard.edu/blog/the-tragedy-of-the-post-covid-long-haulers-2020101521173.

Abaturov A.E., Agafonova E.A., Krivusha E.L., Nikulina A.A. Patogenez COVID-19. Zdorov’e Rebenka. 2020; 15 (2): 133-144.

Lynnyk M.I., Gumeniuk M.I., Liskina I.V., Gumeniuk G.L. ta in. Osobennosti oslozhnennogo techeniya negospitalnoj virusnoj COVID-19 pnevmonii. Georgial Medical News. 2021; 6 (315): 129-134.

Feshchenko Yu.I., Dziublyk O.Ya., Dziublyk Ya.O. Nehospitalna pnevmoniia: monohrafiia. Kyiv: Samit-knyha, 2020. 468 p.

Feshchenko Yu.I., Golubovska O.A., Dziublyk O.Ya., Gavrysiuk V.K. ta in. Osoblivosti urazhennya legen pri COVID-19. Ukr. pulmon. zhurn. 2021; 1: 5-14. DOI: 10.31215/2306-4927-2021-1-5-14.

Kim J., Choe P., Oh Y., et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J. Korean Med. Sci. 2020; 35 (5). e61.

Li Y., Xia L. Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management. Am. J. Roentgenol. 2020; 214 (6): 1280-1286.

Pan Y., Guan H., Zhou S., et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur. Radiol. 2020; 30: 3306-3309.

Shi H., Han X., Jiang N., et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect. Dis. 2020; 20 (4): 425-434.

Zhao W., Zhong Z., Xie X., et al. Relation between chest CT findings and сlіnical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. American J. Roentg. 2020; 214 (5): 1072-1077.

Zheng Z., Yao Z., Wu K., Zheng J. The diagnosis of pandemic coronavirus pneumonia: a review of radiology examination and laboratory test. J. Clin. Virol. 2020; 128: 104396.

Gavrisyuk V.K. KT-semiotika porazheniy legkih pri koronavirusnoi bolezni (COVID-19). Ukr. pulmon. zhurn. 2020; 2: 13-18. DOI: 10.31215/2306-4927-2020-108-2-13-18.

Published
2021-09-24
How to Cite
Feshchenko, Y., LynnykМ., GumeniukМ., Kalabukha, I., ІgnatievaV., Gumeniuk, G., Tarasenko, O., Ivaschenko, V., & Palivoda, M. (2021). Diagnosis of disappearing lung syndrome as a complication of non-hospital pneumonia of viral etiology (COVID-19). Infusion & Chemotherapy, (3), 5-11. https://doi.org/10.32902/2663-0338-2021-3-5-11
Section
ORIGINAL STUDIES

Author Biographies

Y.I. Feshchenko, SI “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky of the NAMS of Ukraine”, Kyiv, Ukraine

Feshchenko Yurii Ivanovych
Director
Academician of the NAMS of Ukraine,
MD, professor.
10, M. Amosova st., Kyiv, 03038, Ukraine.

М.І. Lynnyk, SI “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky of the NAMS of Ukraine”, Kyiv, Ukraine

Lynnyk Mykola Ivanovych
Leading researcher, Department of epidemiology and organizational problems of phthisiology
MD, PhD.
10, M. Amosova st., Kyiv, 03038, Ukraine.

М.І. Gumeniuk, SI “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky of the NAMS of Ukraine”, Kyiv, Ukraine

Gumeniuk Mykola Ivanovych
Leading researcher, Department of technologies of treatment of nonspecific lung diseases
MD, professor.
10, M. Amosova st., Kyiv, 03038, Ukraine.

I.A. Kalabukha, SI “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky of the NAMS of Ukraine”, Kyiv, Ukraine

Kalabukha Igor Anatoliyovych
Deputy director on scientific and scientific-organizational work, head of the thoracic surgery department.
MD, professor.
10, M. Amosova st., Kyiv, 03038, Ukraine.

V.І. Іgnatieva, SI “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky of the NAMS of Ukraine”, Kyiv, Ukraine

Ignatieva Victoria Igorivna
Senior researcher, Department of diagnostics, therapy and clinical pharmacology of lung diseases
PhD.
10, M. Amosova st., Kyiv, 03038, Ukraine.
Е-mail: ignatieva@ifp.kiev.ua
Теl./Fax: +380 44 275 27 33.

G.L. Gumeniuk, National University of Healthcare of Ukraine named after P.L. Shupyk, Kyiv, Ukraine

Gumeniuk Galyna Lvivna
Professor of phthisiology and pulmonology department; Senior Researcher of Treatment, Diagnosis and Clinical Pharmacology of Lung Disease NIFP NAMNU.
MD, professor.
10, M. Amosova st., Kyiv, 03038, Ukraine.

O.R. Tarasenko, SI “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky of the NAMS of Ukraine”, Kyiv, Ukraine

Tarasenko Olena Rostyslavivna
Senior researcher, Department of epidemiology and organizational problems of phthisiology
PhD.
10, M. Amosova st., Kyiv, 03038, Ukraine.

V.E. Ivaschenko, SI “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky of the NAMS of Ukraine”, Kyiv, Ukraine

Ivaschenko Volodymyr Evgenovych
Researcher, Department of thoracic surgery
PhD.
10, M. Amosova st., Kyiv, 03038, Ukraine.

M.G. Palivoda, SI “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky of the NAMS of Ukraine”, Kyiv, Ukraine

Palivoda Mykola Grygorovych
Deputy chief physician
10, M. Amosova st., Kyiv, 03038, Ukraine.